Detection, prediction, and prognosis: blood circulating microRNA as novel molecular markers of head and neck cancer patients

Keyphrases

• Cancer Patients 100%
• Molecular Markers 100%
• Head-and-neck Cancer 100%
• Circulating microRNA 100%
• MicroRNA 50%
• Clinical Prognosis 50%
• Cancer Diagnosis 50%
• Cancer Prognosis 50%
• Cancer Prediction 50%
• Diagnosis Prediction 50%
• Test Validity 25%
• Tumor 25%
• Expert Opinion 25%
• Area Cover 25%
• Tumor Detection 25%
• Routine Clinical Practice 25%
• Cancer Cases 25%
• Methodological Aspects 25%
• Non-invasive Biomarkers 25%
• Cancer Management 25%
• Tumor Heterogeneity 25%
• Tumor Prognosis 25%
• Tumor Prediction 25%
• Universal Markers 25%

Medicine and Dentistry

• Head and Neck Cancer 100%
• Circulating microRNA 100%
• Molecular Marker 100%
• Neoplasm 50%
• microRNA 50%
• Cancer Diagnosis 50%
• Cancer Prognosis 50%
• Malignant Neoplasm 25%
• Tumour Heterogeneity 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Head and Neck Cancer 100%
• Circulating microRNA 100%
• Molecular Marker 100%
• Neoplasm 75%
• microRNA 50%
• Malignant Neoplasm 25%